Henry Schein Inc
Research Henry Schein Inc (HSIC) on Bullrun: valuation model: 11.7% overvalued, market cap USD 9.57B, P/E 24.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHSIC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Valuation signal11.7% overvalued
- Market capUSD 9.57B
- P/E24.5
- Financial periodQ2 2026
- RevenueUSD 3.46B
- Net incomeUSD 94.00M
- Free cash flowUSD 196.00M
- Gross margin31.8%
Valuation Snapshot
Bullrun's latest valuation model marks Henry Schein Inc as 11.7% overvalued; latest market cap is USD 9.57B; P/E is 24.5.
Peer valuation comparison
Latest P/E is 24.48x versus a Healthcare sector median of 24.6x.
Latest P/E is 24.48x versus a United States median of 23.85x (2.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 13.18B | USD 419.00M | USD 573.00M | 31.1% | 3.27 | USD 156.00M | USD 764.00M | USD 3.25B |
| FY2024 | USD 12.67B | USD 398.00M | USD 700.00M | 31.7% | 3.05 | USD 122.00M | USD 650.00M | USD 3.39B |
| FY2023 | USD 12.34B | USD 436.00M | USD 353.00M | 31.3% | 3.16 | USD 171.00M | USD 264.00M | USD 3.66B |
| FY2022 | USD 12.65B | USD 566.00M | USD 506.00M | 30.3% | 3.91 | USD 117.00M | USD 1.15B | USD 3.45B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 9.57B | 24.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 8.75B | 23.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 8.59B | 22.7 | n/a | n/a |
| 2023 | 2023-12-29 | USD 9.84B | 22.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 10.83B | 17.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 10.63B | 17.6 | n/a | n/a |
About Henry Schein Inc
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
ETFs that hold Henry Schein Inc
Henry Schein Inc is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| Inyova Impact Investing Fund | 3.05% | 0.95% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Henry Schein Inc overvalued or undervalued?
Bullrun's valuation model currently marks Henry Schein Inc as 11.7% overvalued.
What is Henry Schein Inc's market cap?
Henry Schein Inc's market capitalization is USD 9.57B.
What is Henry Schein Inc's P/E ratio?
Henry Schein Inc's price-to-earnings (P/E) ratio is 24.5.
What does Henry Schein Inc do?
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.